title: Neuropeptide pituitary adenylate cyclase-activating polypeptide (PACAP) slows down Alzheimer's disease-like pathology in amyloid precursor protein-transgenic mice.
abstract: Pituitary adenylate cyclase-activating polypeptide (PACAP) has neuroprotective and neurotrophic properties and is a potent α-secretase activator. As PACAP peptides and their specific receptor PAC1 are localized in central nervous system areas affected by Alzheimer's disease (AD), this study aims to examine the role of the natural peptide PACAP as a valuable approach in AD therapy. We investigated the effect of PACAP in the brain of an AD transgenic mouse model. The long-term intranasal daily PACAP application stimulated the nonamyloidogenic processing of amyloid precursor protein (APP) and increased expression of the brain-derived neurotrophic factor and of the antiapoptotic Bcl-2 protein. In addition, it caused a strong reduction of the amyloid β-peptide (Aβ) transporter receptor for advanced glycation end products (RAGE) mRNA level. PACAP, by activation of the somatostatin-neprilysin cascade, also enhanced expression of the Aβ-degrading enzyme neprilysin in the mouse brain. Furthermore, daily PAC1-receptor activation via PACAP resulted in an increased mRNA level of both the PAC1 receptor and its ligand PACAP. Our behavioral studies showed that long-term PACAP treatment of APP[V717I]-transgenic mice improved cognitive function in animals. Thus, nasal application of PACAP was effective, and our results indicate that PACAP could be of therapeutic value in treating AD.
authors: Institute of Pharmacy and Biochemistry, Johannes Gutenberg University, Mainz, Germany. kojro@uni-mainz.de
authors: Dorothea
authors: D
authors: Rat
authors: Ulrich
authors: U
authors: Schmitt
authors: Frank
authors: F
authors: Tippmann
authors: Ilse
authors: I
authors: Dewachter
authors: Clara
authors: C
authors: Theunis
authors: Ewa
authors: E
authors: Wieczerzak
authors: Rolf
authors: R
authors: Postina
authors: Fred
authors: F
authors: van Leuven
authors: Falk
authors: F
authors: Fahrenholz
authors: Elzbieta
authors: E
authors: Kojro
references: J Neurochem. 2000 Feb;74(2):501-7
references: 10646500
references: EMBO J. 2010 Sep 1;29(17):3020-32
references: 20676056
references: Neurobiol Aging. 2006 Mar;27(3):377-86
references: 15927307
references: Cell. 2010 Jul 23;142(2):320-32
references: 20655472
references: Neurosci Lett. 2000 Jan 14;278(3):169-72
references: 10653020
references: J Pharmacol Exp Ther. 2002 Apr;301(1):391-400
references: 11907197
references: Brain Res. 1996 Oct 14;736(1-2):280-6
references: 8930334
references: Eur J Pharm Sci. 2000 Jul;11(1):1-18
references: 10913748
references: Eur J Neurosci. 1998 Jan;10(1):272-80
references: 9753136
references: Brain Res Mol Brain Res. 2000 Mar 29;76(2):347-54
references: 10762711
references: J Geriatr Psychiatry Neurol. 2009 Mar;22(1):3-9
references: 19073834
references: Eur J Clin Invest. 2007 Aug;37(8):665-72
references: 17635578
references: J Pharmacol Exp Ther. 2000 Jun;293(3):1091-8
references: 10869414
references: Peptides. 2007 Sep;28(9):1753-60
references: 17655978
references: Nat Med. 2005 Apr;11(4):434-9
references: 15778722
references: Brain Res Mol Brain Res. 2003 Jul 4;115(1):10-20
references: 12824050
references: Neuron. 2006 Mar 2;49(5):671-82
references: 16504943
references: Eur J Neurosci. 2010 Oct;32(8):1246-55
references: 20950278
references: Neurology. 2008 Feb 5;70(6):440-8
references: 17942819
references: Development. 2004 May;131(9):2173-81
references: 15073156
references: J Mol Med (Berl). 2005 Nov;83(11):876-86
references: 16133426
references: Neuroreport. 1997 Jul 7;8(9-10):2133-7
references: 9243598
references: J Biol Chem. 2002 Aug 30;277(35):32046-53
references: 12058030
references: J Neurochem. 2011 May;117(3):403-11
references: 21244427
references: Neurosci Lett. 2004 May 6;361(1-3):128-31
references: 15135910
references: Neuron. 1998 Apr;20(4):727-40
references: 9581764
references: J Clin Invest. 2004 May;113(10):1456-64
references: 15146243
references: Neurosci Lett. 1997 May 23;227(3):145-8
references: 9185671
references: Science. 2002 Jul 19;297(5580):353-6
references: 12130773
references: Nature. 1993 Sep 9;365(6442):170-5
references: 8396727
references: Neuroscience. 2009 Aug 18;162(2):234-43
references: 19393300
references: J Neurosci. 2007 Mar 7;27(10):2628-35
references: 17344400
references: Neuron. 1993 Feb;10(2):243-54
references: 8094963
references: Diabetes. 2001 Dec;50(12):2792-808
references: 11723063
references: Neurobiol Dis. 2008 Aug;31(2):250-60
references: 18585048
references: Peptides. 2007 Sep;28(9):1856-70
references: 17512639
references: FASEB J. 2006 Mar;20(3):512-4
references: 16401644
references: Biochem Biophys Res Commun. 2002 Dec 6;299(3):373-6
references: 12445809
references: Brain Res. 1994 Feb 21;637(1-2):197-203
references: 7910101
references: Pharmacol Rev. 2009 Sep;61(3):283-357
references: 19805477
references: J Neurosci. 2004 Jul 28;24(30):6799-809
references: 15282285
references: Biochem Biophys Res Commun. 2002 Oct 11;297(5):1181-5
references: 12372411
references: Proc Natl Acad Sci U S A. 2006 May 9;103(19):7488-93
references: 16651528
references: Nat Neurosci. 2002 Jun;5(6):514-6
references: 11992114
references: J Biol Chem. 2001 Jan 5;276(1):369-80
references: 11029467
references: Arch Neurol. 1997 May;54(5):641-4
references: 9152122
references: Cell. 1994 Jun 17;77(6):817-27
references: 8004671
references: Neuron. 1998 Apr;20(4):709-26
references: 9581763
references: J Alzheimers Dis. 2010;20(4):1215-31
references: 20413873
references: J Neurosci. 2002 May 1;22(9):3445-53
references: 11978821
references: Proc Natl Acad Sci U S A. 1993 Sep 1;90(17):7951-5
references: 8367446
references: Nature. 1996 Aug 22;382(6593):685-91
references: 8751438
references: Peptides. 2007 Sep;28(9):1891-5
references: 17582655
references: Nat Med. 1995 Aug;1(8):829-32
references: 7585189
references: Biochem Biophys Res Commun. 2006 Mar 31;342(1):206-13
references: 16472763
references: Int J Pharm. 2003 Apr 14;255(1-2):87-97
references: 12672605
references: Neurosci Lett. 2004 Apr 22;360(1-2):106-8
references: 15082190
references: Brain Res Mol Brain Res. 1996 Sep 5;41(1-2):157-62
references: 8883947
references: J Neuroimmune Pharmacol. 2007 Mar;2(1):81-6
references: 18040829
references: J Biol Chem. 1999 Mar 5;274(10):6483-92
references: 10037741
references: FASEB J. 2009 Jun;23(6):1643-54
references: 19144697
references: Biochem Biophys Res Commun. 1990 May 16;168(3):1027-33
references: 2346475
references: Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):13390-5
references: 11087878
references: Glia. 2001 Jul;35(1):72-9
references: 11424194
references: Neuron. 1991 Nov;7(5):695-702
references: 1742020
references: J Aerosol Med. 2006 Spring;19(1):92-9
references: 16551220
references: J Biol Chem. 1996 Feb 23;271(8):4188-94
references: 8626761
references: FEBS Lett. 2005 Jul 18;579(18):4005-11
references: 16004991